Logo image of MBI-H.CA

MANY BRIGHT IDEAS TECHNOLOGI (MBI-H.CA) Stock Fundamental Analysis

Canada - TSX Venture Exchange - TSX-V:MBI-H - CA5650851077 - Common Stock

0.02 CAD
0 (0%)
Last: 1/9/2026, 7:00:00 PM
Fundamental Rating

1

Taking everything into account, MBI-H scores 1 out of 10 in our fundamental rating. MBI-H was compared to 23 industry peers in the Biotechnology industry. MBI-H has a bad profitability rating. Also its financial health evaluation is rather negative. MBI-H does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • MBI-H had negative earnings in the past year.
  • In the past year MBI-H has reported a negative cash flow from operations.
  • In the past 5 years MBI-H always reported negative net income.
  • In multiple years MBI-H reported negative operating cash flow during the last 5 years.
MBI-H.CA Yearly Net Income VS EBIT VS OCF VS FCFMBI-H.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100K -200K -300K

1.2 Ratios

  • Looking at the Return On Assets, with a value of -641.46%, MBI-H is doing worse than 78.26% of the companies in the same industry.
Industry RankSector Rank
ROA -641.46%
ROE N/A
ROIC N/A
ROA(3y)-2058.38%
ROA(5y)-1367.53%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MBI-H.CA Yearly ROA, ROE, ROICMBI-H.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 0 0 0 0 0 0 0 0 0 0

1.3 Margins

  • MBI-H does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MBI-H.CA Yearly Profit, Operating, Gross MarginsMBI-H.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

1

2. Health

2.1 Basic Checks

  • Compared to 1 year ago, MBI-H has about the same amount of shares outstanding.
  • MBI-H has more shares outstanding than it did 5 years ago.
  • MBI-H has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MBI-H.CA Yearly Shares OutstandingMBI-H.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
MBI-H.CA Yearly Total Debt VS Total AssetsMBI-H.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20K 40K 60K

2.2 Solvency

  • Based on the Altman-Z score of -2588.07, we must say that MBI-H is in the distress zone and has some risk of bankruptcy.
  • MBI-H has a worse Altman-Z score (-2588.07) than 73.91% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2588.07
ROIC/WACCN/A
WACCN/A
MBI-H.CA Yearly LT Debt VS Equity VS FCFMBI-H.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50K -50K -100K -150K

2.3 Liquidity

  • MBI-H has a Current Ratio of 0.04. This is a bad value and indicates that MBI-H is not financially healthy enough and could expect problems in meeting its short term obligations.
  • MBI-H's Current ratio of 0.04 is on the low side compared to the rest of the industry. MBI-H is outperformed by 73.91% of its industry peers.
  • MBI-H has a Quick Ratio of 0.04. This is a bad value and indicates that MBI-H is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of MBI-H (0.04) is worse than 73.91% of its industry peers.
Industry RankSector Rank
Current Ratio 0.04
Quick Ratio 0.04
MBI-H.CA Yearly Current Assets VS Current LiabilitesMBI-H.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50K 100K 150K

More info and screens

1

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 8.82% over the past year.
EPS 1Y (TTM)8.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
MBI-H.CA Price Earnings VS Forward Price EarningsMBI-H.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MBI-H.CA Per share dataMBI-H.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0 -0.01 -0.01

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

  • MBI-H does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

MANY BRIGHT IDEAS TECHNOLOGI

TSX-V:MBI-H (1/9/2026, 7:00:00 PM)

0.02

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners22.49%
Ins Owner ChangeN/A
Market Cap305.20K
Revenue(TTM)N/A
Net Income(TTM)-52.60K
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS-0.02
TBVpS-0.02
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -641.46%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-2058.38%
ROA(5y)-1367.53%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.04
Quick Ratio 0.04
Altman-Z -2588.07
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.33%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y6.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-31700%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-31700%
OCF growth 3YN/A
OCF growth 5YN/A

MANY BRIGHT IDEAS TECHNOLOGI / MBI-H.CA FAQ

Can you provide the ChartMill fundamental rating for MANY BRIGHT IDEAS TECHNOLOGI?

ChartMill assigns a fundamental rating of 1 / 10 to MBI-H.CA.


Can you provide the valuation status for MANY BRIGHT IDEAS TECHNOLOGI?

ChartMill assigns a valuation rating of 0 / 10 to MANY BRIGHT IDEAS TECHNOLOGI (MBI-H.CA). This can be considered as Overvalued.


What is the profitability of MBI-H stock?

MANY BRIGHT IDEAS TECHNOLOGI (MBI-H.CA) has a profitability rating of 0 / 10.


How financially healthy is MANY BRIGHT IDEAS TECHNOLOGI?

The financial health rating of MANY BRIGHT IDEAS TECHNOLOGI (MBI-H.CA) is 1 / 10.